ID: ALA4294672

Max Phase: Preclinical

Molecular Formula: C10H17N3O2S

Molecular Weight: 243.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC1(CC)SC(NC(C)=O)=NN1C(C)=O

Standard InChI:  InChI=1S/C10H17N3O2S/c1-5-10(6-2)13(8(4)15)12-9(16-10)11-7(3)14/h5-6H2,1-4H3,(H,11,12,14)

Standard InChI Key:  WSLDUSCDNPSPRD-UHFFFAOYSA-N

Associated Targets(Human)

Kinesin-like protein 1 1720 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 243.33Molecular Weight (Monoisotopic): 243.1041AlogP: 1.51#Rotatable Bonds: 2
Polar Surface Area: 61.77Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.69CX Basic pKa: CX LogP: 1.36CX LogD: 1.36
Aromatic Rings: 0Heavy Atoms: 16QED Weighted: 0.80Np Likeness Score: -0.99

References

1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F..  (2018)  Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors.,  156  [PMID:30031975] [10.1016/j.ejmech.2018.07.006]

Source